Literature DB >> 9432120

Prevalence of human GH-1 gene alterations in patients with isolated growth hormone deficiency.

J K Wagner1, A Eblé, P C Hindmarsh, P E Mullis.   

Abstract

Human GH is encoded by the GH-1 gene which belongs to the GH gene cluster encompassing a distance of about 65 kb on the long arm of chromosome 17. Familial isolated growth hormone deficiency (IGHD) is associated with at least four Mendelian disorders. These include two forms that have autosomal recessive inheritance (IGHD types IA and IB) as well as autosomal dominant (IGHD type II) and X-linked (IGHD III) forms. The aim of our study was to evaluate the prevalence of all GH-1 gene alterations by sequencing the whole GH-1 gene after PCR amplification among 151 affected subjects from 83 families with severe IGHD (height: <-4.5 SD score). A high frequency of GH-1 gene alterations was found in families with IGHD type IA (8/12, 66.7%), whereas only a low frequency of GH-1 gene defects was present in all the other GH-deficient families (7/71, 9.9%). The absolute frequency of GH-1 gene deletions was 8.7% (6/69), 11.8% (4/34), and 18.7% (9/48) in Northern Europeans, Mediterraneans, and Asians, respectively, giving an overall frequency of 12.5% (19/151). The sizes of the deletions were heterogeneous with the most frequent (78%) being 6.7 kb. In addition, 6% (9/151) of the patients presented GH-1 gene mutations such as frameshift, stop codon and splicing error. Furthermore, total GH-1 gene abnormalities varied among different populations from 11.6% in Northern Europe, 14.7% in Mediterranean countries and 31.2% in Asia. Most striking, however, was the low frequency rate of 1.7% (2/119) of GH-1 gene mutations responsible for the most common phenotype of IGHD, namely type IB, among the subjects characterized by the production of deficient but detectable amounts of GH after provocative stimuli. This finding underlines the necessity to focus rather on the promoter region of the GH-1 gene (cis-acting elements and trans-acting factors), and on other candidate genes specific for the GH axis than the GH-1 gene itself to define genetically the IGHD type IB phenotype in more detail.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9432120     DOI: 10.1203/00006450-199801000-00016

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  19 in total

Review 1.  GH Gene Deletions and IGHD type IA.

Authors:  Chanda T Moseley; Matthew D Orenstein; John A Phillips
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

Review 2.  Growth hormone and IGF-1.

Authors:  Roberto Salvatori
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

3.  Growth hormone (GH-1) gene deletions in children with isolated growth hormone deficiency (IGHD).

Authors:  Meena P Desai; Shilpa M Mithbawkar; Pradnya S Upadhye; Kavita K Shalia
Journal:  Indian J Pediatr       Date:  2011-10-21       Impact factor: 1.967

4.  Molecular genetic studies in isolated growth hormone deficiency (IGHD).

Authors:  Meena P Desai; Shilpa M Mithbawkar; Pradnya S Upadhye; Sudha C Rao; Vijayalakshmi Bhatia; Madhava Vijaykumar
Journal:  Indian J Pediatr       Date:  2013-02-23       Impact factor: 1.967

5.  Growth plate alterations in chronic kidney disease.

Authors:  Ángela Fernández-Iglesias; José Manuel López; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2018-12-14       Impact factor: 3.714

Review 6.  Phenotype-genotype correlations in congenital isolated growth hormone deficiency (IGHD).

Authors:  Kyriaki S Alatzoglou; Mehul T Dattani
Journal:  Indian J Pediatr       Date:  2011-12-03       Impact factor: 1.967

Review 7.  Genetic causes and treatment of isolated growth hormone deficiency-an update.

Authors:  Kyriaki S Alatzoglou; Mehul T Dattani
Journal:  Nat Rev Endocrinol       Date:  2010-10       Impact factor: 43.330

Review 8.  Molecular defects in the growth hormone-IGF axis.

Authors:  Joyce Lee; Ram K Menon
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

Review 9.  Isolated growth hormone deficiency.

Authors:  Libia M Hernández; Phillip D K Lee; Cecilia Camacho-Hübner
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 10.  The molecular basis of hypopituitarism.

Authors:  Christopher J Romero; Suzana Nesi-França; Sally Radovick
Journal:  Trends Endocrinol Metab       Date:  2009-10-23       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.